Skip to content

The Reliability and Validity of the Functional Reach Test in Patients With Multiple Sclerosis

The Reliability and Validity of the Functional Reach Test in Patients With Multiple Sclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04185688
Enrollment
79
Registered
2019-12-04
Start date
2019-12-06
Completion date
2020-02-07
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple Sclerosis, Functional reach test, Reliability, Validity

Brief summary

Loss of limits of stability ability is one of the major components of balance dysfunction in MS. The functional reach test is quick and clinically available tool for assessing limits of stability but reliability and validity of this test has not yet been systematically examined in people with Multiple Sclerosis.The aim of the study is to investigate reliability and validity of the functional reach test in patients with Multiple Sclerosis.

Detailed description

At baseline, the functional reach test, limits of stability test by using Biodex Balance System, Berg Balance Scale, four step square test, and timed up and go test was applied to the patients with Multiple Sclerosis. The functional reach test was repeated after seven days from the first application to evaluate its reliability.

Interventions

The Functional Reach Test assesses balance by measuring the limits of stability while the patient reaches forwards as far as possible, having the arms in 90° flexion and without lifting the heels off the floor.

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* at least 18 years, * neurologist-diagnosed Multiple Sclerosis, * Expanded Disability Status Scale (EDSS) score \< 7, * able to walk 20 m with or without aids, * no MS exacerbation within the last 2 months, * use of stable medication in the last 2 months.

Exclusion criteria

* other neurologic disorder, * pregnancy, * orthopedic problems affecting gait and stance, * visual, auditory, orientational problems that could affect study results, * cardiovascular, pulmonary, and humoral disease.

Design outcomes

Primary

MeasureTime frameDescription
Functional Reach Test30 secondsFunctional Reach Test is clinically used to assess limits of stability.

Secondary

MeasureTime frameDescription
Biodex Balance System2 minutesBiodex Balance System is used to assess limits of stability.
Berg Balance Scale10 minutesBerg Balance Scale is used to assess functional balance. Berg Balance Scale is a 14-item related to daily living activities that is scored between 0 and 4. The maximum score is 56 points and higher scores represent better balance.
Four Square Step Test20 secondsFour Square Step Test is used to assess dynamic balance.
Timed Up and Go Test15 secondsTimed Up and Go Test is used to assess functional mobility.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026